1.上海中医药大学附属光华医院(上海 200052)
2.陕西中医药大学(陕西 西安 712046)
3.西安医学院第二附属医院(陕西 西安 710038)
4.上海市第三康复医院(上海 200436)
5.上海市浦东新区浦南医院(上海 200125)
6.上海市静安区市北医院(上海 200443)
7.上海理工大学附属市东医院(上海 200438)
扫 描 看 全 文
宫政,李菲,陈松美等.艾灸督脉治疗脑梗死恢复期临床疗效观察[J].上海中医药大学学报,2023,37(02):35-40.
GONG Zheng,LI Fei,CHEN Songmei,et al.Clinical observation of moxibustion on Du meridian in treatment of cerebral infarction in recovery period[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(02):35-40.
宫政,李菲,陈松美等.艾灸督脉治疗脑梗死恢复期临床疗效观察[J].上海中医药大学学报,2023,37(02):35-40. DOI: 10.16306/j.1008-861x.2023.02.006.
GONG Zheng,LI Fei,CHEN Songmei,et al.Clinical observation of moxibustion on Du meridian in treatment of cerebral infarction in recovery period[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(02):35-40. DOI: 10.16306/j.1008-861x.2023.02.006.
目的,2,采用多中心、随机对照方法评价艾灸督脉治疗脑梗死(CI)恢复期患者的临床疗效。,方法,2,纳入212例CI恢复期患者,随机分为对照组和治疗组,每组各106例。两组患者均给予常规治疗,在此基础上,治疗组患者给予艾灸督脉治疗,治疗周期为12周。评价并比较两组患者的临床疗效。治疗前后,评价所有患者的美国国立卫生研究院卒中量表(NIHSS)评分、Barthel指数(BI)评分,检测患者的神经元特异性烯醇化酶(NSE)、免疫球蛋白(Ig)A、IgG、IgM及白介素(IL)-6、肿瘤坏死因子-α(TNF-α)水平。,结果,2,治疗过程中,对照组剔除或脱落7例患者,治疗组剔除或脱落7例患者,最终纳入统计分析者对照组99例、治疗组99例。①治疗后,治疗组患者的临床总有效率为79.8%,对照组为61.6%,治疗组的疗效优于对照组(,P,<,0.05)。②治疗后,两组患者的NIHSS评分较治疗前明显下降(,P,<,0.05)、BI评分较治疗前显著升高(,P,<,0.05),且治疗组患者的NIHSS评分低于对照组、BI评分高于对照组(,P,<,0.05)。③治疗后,治疗组患者的NSE、TNF-α水平较治疗前明显降低(,P,<,0.05),且低于对照组(,P,<,0.05);治疗组患者的IgG水平较治疗前升高(,P,<,0.05),且高于对照组(,P,<,0.05)。,结论,2,艾灸督脉治疗CI恢复期患者,可改善患者的神经功能缺损,提高患者的日常生活能力,其机制可能与调节患者的免疫功能、降低炎症因子水平、缓解脑损伤有关。
Objective: To evaluate the efficacy of moxibustion on Du meridian in the treatment of cerebral infarction (CI) in recovery period by multicenter randomized controlled study.,Methods,2,A total of 212 patients with CI in recovery period were included and randomly divided into the control group and treatment group, 106 cases in each group. The patients in both groups were treated with conventional therapy. Based on above, the patients in the treatment group were treated with moxibustion on Du meridian. The treatment course was 12 weeks. The clinical efficacy of the two groups was evaluated and compared. Before and after treatment, the scores of National Institutes of Health Stroke Scale (NIHSS) and Barthel Index (BI) were evaluated, and the levels of Neuron-specific enolase (NSE), immunoglobulin (Ig)A, IgG, IgM, interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) were detected.,Results,2,During the treatment, 7 patients in the control group and 7 patients in the treatment group were excluded or dropped out. Finally, 99 cases in the control group and 99 cases in the treatment group were included in the statistical analysis. ①After treatment, the clinical total effective rate was 79.8% in the treatment group and 61.6% in the control group, and the efficacy of the treatment group was better than that of the control group (,P,<,0.05). ②After treatment, the NIHSS scores in the two groups were significantly decreased compared with those before treatment,(,P,<,0.05), and the BI scores were significantly increased compared with those before treatment,(,P,<,0.05). Additionally, the NIHSS score of the treatment group was lower than that of the control group and the BI score was higher than that of the control group (,P,<,0.05). ③After treatment, the levels of NSE and TNF-α in the treatment group were significantly decreased compared with those before treatment (,P,<,0.05), and were lower than those in the control group (,P,<,0.05). The level of IgG in the treatment group was increased compared with that before treatment (,P,<,0.05), and were higher than that in the control group (,P,<,0.05).,Conclusion,2,Moxibustion on Du meridian can improve the neurological deficits and enhance the activity of daily living in treating patients with CI in recovery period. Its mechanisms may be related to regulating the immune function, reducing the levels of inflammatory factors and alleviating brain injury.
脑梗死恢复期艾灸督脉免疫指标炎症因子神经功能损伤
cerebral infarctionrecovery periodmoxibustionDu meridianimmune indexinflammatory factornerve function injury
LEE S H, PARK S Y, JANG M U, et al. Association between Osteoporosis and Cognitive Impairment during the Acute and Recovery Phases of Ischemic Stroke[J]. Medicina (Kaunas), 2020, 56(6): 307.
DE COCK E, OOSTRA K, BLIKI L, et al. Dysarthria following acute ischemic stroke: Prospective evaluation of characteristics, type and severity[J]. Int J Lang Commun Disord, 2021, 56(3): 549-557.
韩丹, 刘天时, 臧金鹏, 等. 温阳通络汤结合胞磷胆碱对脑梗死恢复期血脂的影响[J]. 中华中医药学刊, 2022, 40(1): 225-228.
HAN D, LIU T S, ZANG J P, et al. Study on Effect of Wenyang Tongluo Decoction Combined with Cytidine Choline on Blood Lipid in Patients with Cerebral Infarction during Convalescence[J]. Chinese Archives of Traditional Chinese Medicine, 2022, 40(1): 225-228.
中国中西医结合学会神经科专业委员会. 中国脑梗死中西医结合诊治指南(2017)[J]. 中国中西医结合杂志, 2018, 38(2): 136-144.
Professional Committee of Neurology, Chinese Society of Integrated Traditional and Western Medicine. Chinese Guidelines for the Diagnosis and Treatment of Integrated Traditional and Western Medicine of Cerebral Infarction (2017)[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2018, 38(2): 136-144.
张旭. 《中国急性缺血性脑卒中诊治指南2014》解读[C]//2016年临床药学高峰论坛暨浙江省医学会临床药学分会学术会议论文汇编. 宁波: 浙江省医学会临床药学分会, 2016: 108-115.
ZHANG X. Interpretation of Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2014[C]//2016 Clinical Pharmacy Summit Forum and Zhejiang Medical Association Clinical Pharmacy Branch Academic Conference Paper Compilation. Ningbo: Clinical Pharmacy Branch of Zhejiang Medical Association, 2016: 108-115.
秦俭. 急性脑卒中急诊救治——2005美国心脏学会心肺复苏与心血管急救指南中国脑血管病防治指南[C]//第十二届全国复苏与中毒学术会议论文汇编. 乌鲁木齐: 中华医学会急诊医学分会, 2007: 88-108.
QIN J. Emergency treatment of acute stroke—2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Chinese Guidelines for Prevention and Treatment of Cerebrovascular Disease[C]//The 12th National Recovery and Poisoning Academic Conference Paper Compilation. Urumqi: Emergency Medicine Branch of Chinese Medical Association, 2007: 88-108.
李平, 吴钟璇, 张云如, 等. 中风病诊断与疗效评定标准(试行)[J]. 北京中医药大学学报, 1996, 19(1): 55-56.
LI P, WU Z X, ZHANG Y R, et al. Criterion of Diagnosis and Therapeutic Effect of Apoplexy (trial) [J]. Journal of Beijing University of Traditional Chinese Medicine, 1996, 19(1): 55-56.
BROTT T, JrADAMS H P, OLINGER C P, et al. Measurements of acute cerebral infarction: a clinical examination scale[J]. Stroke, 1989, 20(7): 864-870.
MAHONEY F I, BARTHEL D W. Functional evaluation: the barthel index [J] Md State Med J, 1965, 14: 61-65.
陈惠冰, 杨绮云, 郭小妹. 艾灸疗法的不良反应及安全性分析[J]. 河南中医, 2021, 41(6): 935-938.
CHEN H B, YANG Q Y, GUO X M. An Analysis of Adverse Reactions and Safety of Moxibustion Therapy [J]. Henan Traditional Chinese Medicine, 2021, 41(6): 935-938.
唐斐斐, 韩如章, 姜翔, 等. 中医治疗脑血管疾病的临床探究[J]. 中西医结合心血管病电子杂志, 2020, 8(34): 187-188.
TANG F F, HAN R Z, JIANG X, et al. Clinical Study on TCM Treatment of Cerebrovascular Disease[J]. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine, 2020, 8(34): 187-188.
郑天洋, 姜宏, 金日华, 等. 缺血性卒中后的炎症与免疫反应[J]. 中风与神经疾病杂志, 2018, 35(3): 282-284.
ZHENG T Y, JIANG H, JIN R H, et al. Inflammation and immune response after ischemic stroke[J]. Journal of Apoplexy and Nervous Diseases, 2018, 35(3): 282-284.
时芳芳, 胡加运, 杨颖楠, 等. STIM1蛋白、尿蛋白、GST在急性缺血性脑梗死中的表达及临床意义[J].分子诊断与治疗杂志, 2022, 14(3): 401-404.
SHI F F, HU J Y, YANG Y N, et al. Expression and clinical significance of STIM1 protein, urine protein and GST in acute ischemic cerebral infarction[J]. Journal of Molecular Diagnostics and Therapy, 2022, 14(3): 401-404.
贺雯, 高尚, 宋海燕, 等. Hcy、D-D、NSE与急性缺血性脑卒中的相关性研究[J]. 中国煤炭工业医学杂志, 2015, 18(12): 2017-2024.
HE W, GAO S, SONG H Y, et al. Research on homocysteine, D-Dimer, Specific enolase in acute ischemic stroke[J]. Chinese Journal of Coal Industry Medicine, 2015, 18(12): 2017-2024.
袁晓帆, 王建红, 王多姿, 等. 神经元特异性烯醇化酶、S100 B蛋白在脑缺血损伤中的研究进展[J]. 实用医院临床杂志, 2019, 16(6): 237-239.
YUAN X F, WANG J H, WANG D Z, et al. Research progress of NSE and S100 B protein in cerebral ischemic injury[J]. Practical Journal of Clinical Medicine, 2019, 16(6): 237-239.
李超, 朱才丰, 王雪伟. 艾灸督脉组穴治疗卒中后认知障碍的临床研究[J]. 针灸临床杂志, 2022, 38(4): 27-32.
LI C, ZHU C F, WANG X W. Clinical Study of Du Meridian Moxibustion in Treating PSCI[J]. Journal of Clinical Acupuncture and Moxibustion, 2022, 38(4): 27-32.
陈巧风. 艾灸联合护理程序干预对脑卒中患者吞咽困难症状康复的影响[J]. 新乡医学院学报, 2020, 37(3): 291-295.
CHEN Q F. Effect of moxibustion combined with nursing program intervention on dysphagia symptom rehabilitation in patients with stroke[J]. Journal of Xinxiang Medical University, 2020, 37(3): 291-295.
阮静茹, 杨坤, 宋小鸽, 等. 艾灸对血管性痴呆大鼠海马炎性因子及微管相关蛋白表达的影响[J]. 针刺研究, 2020, 45(10): 781-788.
RUAN J R, YANG K, SONG X G, et al. Effect of moxibustion on learning-memory ability and expression of hippocampal inflammatory factors and microtubule associated proteins in vascular dementia rats[J]. Acupuncture Research, 2020, 45(10): 781-788.
肖爱娇, 肖移生, 欧阳昕, 等. 艾灸对缺氧缺血性脑病新生小鼠脑组织炎症细胞浸润和CD11b表达的影响[J]. 天津医药, 2019, 47(1): 19-22.
XIAO A J, XIAO Y S, OUYANG X, et al. Effect of moxibustion on inflammatory cell infiltration and CD11b expression in brain tissue of neonatal mice with hypoxic-ischemic encephalopathy[J]. Tianjin Medical Journal, 2019, 47(1): 19-22.
郭诗琪, 和蕊, 姚琴, 等. 艾灸疗法在免疫相关疾病中的应用概况[J]. 中国医药导报, 2020, 17(25): 42-44.
GUO S Q, HE R, YAO Q, et al. Application of moxibustion therapy in immune related diseases[J]. China Medical Herald, 2020, 17(25): 42-44.
邓柏颖, 杨力强, 罗敏然. 化脓灸提高“体虚易感”患者免疫力的临床研究[J]. 四川中医, 2005, 23(1): 86-87.
DENG B Y, YANG L Q, LUO M R. Clinical study on improving immunity of patients with “body deficiency susceptibility” by purulent moxibustion[J]. Journal of Sichuan Traditional Chinese Medicine, 2005, 23(1): 86-87.
张红运, 卢圣锋, 肖农. 神阙、关元穴温和灸防治脑瘫儿反复呼吸道感染的临床观察[J]. 中国中西医结合杂志, 2010, 30(9): 935-937.
ZHANG H Y, LU S F, XIAO N. Effects of Mild Warming Moxibustion on Acupoints Shenque (RN8) and Guanyuan (RN4) for Prevention and Treatment of Recurrent Respiratory Tract Infection in Children with Cerebral Palsy[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2010, 30(9): 935-937.
张伟, 陈明人, 熊俊. 不同灸量悬灸“大椎”穴对哮喘大鼠细胞免疫学机制的影响[J]. 针刺研究, 2012, 37(3): 202-205, 217.
ZHANG W, CHEN M R, XIONG J. Effects of Different Quantity of Moxibustion at “Dazhui” (GV 14) on Cellular Immunity in Asthma Rats[J]. Acupuncture Research, 2012, 37(3): 202-205, 217.
李晓泓, 王洪彬, 徐莉莉, 等. 逆针灸“关元”穴对更年期大鼠脾脏热休克蛋白70及其 mRNA 表达和血清白介素-2、肿瘤坏死因子-α含量的影响[J]. 针刺研究, 2009, 34(2): 83-88.
LI X H, WANG H B, XU L L, et al. Effect of Preventive Acupuncture and Moxibustion at “Guanyuan” (CV 4) on the Expression of HSP 70 and HSP 70 mRNA in Spleen and the Contents of Serum IL-2,TNF-α in Menopausal Rats[J]. Acupuncture Research, 2009, 34(2): 83-88.
陈滢宇. 艾灸调节HIV/AIDS患者免疫功能的探讨[J]. 中国中医基础医学杂志, 2011, 17(11): 1256-1257.
CHEN Y Y. Discussion on regulative effects of moxibustion on immune functions of HIV/AIDS patients[J]. Journal of Basic Chinese Medicine, 2011, 17(11): 1256-1257.
李学智. 骑竹马灸疗效的心理应激免疫机制探讨[J]. 中国针灸, 2010, 30(2): 165-167.
LI X Z. Discussion on the mechanism of immune response to psychological stress of Qi Zhuma moxibustion therapy[J]. Chinese Acupuncture & Moxibustion, 2010, 30(2): 165-167.
田华张, 陈俊玲. 艾灸强壮穴位对慢性疲劳综合征患者免疫功能的影响[J]. 深圳中西医结合杂志, 2006, 16(4): 226-227.
TIAN H Z, CHEN J L. Effect of moxibustion at strong acupoints on immune function in patients with chronic fatigue syndrome[J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2006,16(4): 226-227.
徐中菊, 舒适, 黄金阳, 等. 督灸联合阿托伐他汀对气虚血瘀型脑梗死病人颈动脉斑块及脑梗死复发的影响[J]. 中西医结合心脑血管病杂志, 2017, 15(15): 1823-1825.
XU Z J, SHU S, HUANG J Y, et al. The Influence of Du-moxibustion and Atorvastatin on Carotid Plaques and Recurrence in Patients with Cerebral Infarction and Qi Deficient and Blood Stasis Syndrome[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2017, 15(15): 1823-1825.
0
Views
207
下载量
0
CSCD
2
CNKI被引量
Publicity Resources
Related Articles
Related Author
Related Institution